Acebutolol
Acebutolol Gedeon Richter belongs to a group of medicines known as beta-adrenergic blockers.
The main effects of Acebutolol Gedeon Richter are: reducing heart rate frequency
(especially during exercise) and lowering blood pressure in patients with hypertension.
Acebutolol Gedeon Richter also has an antiarrhythmic effect.
Acebutolol Gedeon Richter is a cardioselective (selective for the heart) beta-adrenergic blocker. It mainly inhibits the response to stimulation of adrenergic receptors located in the heart, while having less affinity for adrenergic receptors located in the bronchial wall and peripheral arteries.
Acebutolol Gedeon Richter has the ability of partial stimulation of beta-adrenergic receptors in the heart, also known as intrinsic sympathomimetic activity (ISA). In patients at rest, this ensures a balance between the negative dromotropic effect (slowing of electrical impulse conduction in the heart's conduction system) and the negative inotropic effect (decrease in heart muscle contraction force) of Acebutolol Gedeon Richter, thus reducing the risk of conduction disorders and heart failure.
Acebutolol Gedeon Richter counteracts the effects of excessive amounts of catecholamines in the blood (mainly adrenaline and noradrenaline) under stress conditions.
Acebutolol Gedeon Richter should not be taken if the patient has:
Acebutolol Gedeon Richter should not be taken by children.
Bronchial asthma and chronic obstructive pulmonary disease
Acebutolol Gedeon Richter has a less pronounced bronchoconstrictive effect than other non-selective beta-adrenergic blockers. Nevertheless, the medicine should be used in patients with bronchial asthma and chronic obstructive pulmonary disease only if necessary.
Beta-adrenergic blocker-induced bronchospasm is at least partially reversible by the use of appropriate bronchodilators (usually in the form of a pressure inhaler).
Heart failure
In the case of heart failure (compensated), the medicine should be used with caution, under close medical supervision.
Bradycardia
If the patient's heart rate at rest is less than 45-50 beats per minute and symptoms of bradycardia occur (dizziness, fainting), the daily dose of Acebutolol Gedeon Richter should be reduced by the doctor.
First-degree atrioventricular block
Acebutolol Gedeon Richter should be used with caution in the case of first-degree atrioventricular block, as it slows down the conduction of impulses in the heart and may exacerbate the symptoms of this block.
Peripheral circulation disorders
Acebutolol Gedeon Richter may exacerbate the symptoms of ischemia caused by peripheral artery insufficiency, such as in Raynaud's disease, Buerger's disease, other inflammatory artery diseases, and diffuse atherosclerotic changes in peripheral arteries in smokers or patients with diabetes. In these diseases, the medicine should be used with caution. If the symptoms of ischemia worsen, the patient should consult a doctor.
Pheochromocytoma
In patients with pheochromocytoma, Acebutolol Gedeon Richter can be started after prior pharmacological blockade of alpha-adrenergic receptors.
Hyperthyroidism
Caution should be exercised when using Acebutolol Gedeon Richter in patients with hyperthyroidism, as the medicine may mask the symptoms of the disease.
Kidney function disorders
Caution should be exercised when using Acebutolol Gedeon Richter in patients with severe kidney impairment. In patients with kidney function disorders, the dose of the medicine should be adjusted by the doctor based on the laboratory parameter determining kidney function - creatinine clearance, while maintaining a once-daily dosing regimen.
Diabetes
At the beginning of treatment with Acebutolol Gedeon Richter, it should be remembered that the medicine may mask the symptoms of hypoglycemia, especially tachycardia (increased heart rate at rest above 100 beats/minute), palpitations, excessive sweating, and may increase the risk of severe hypoglycemia, so blood sugar levels should be monitored more frequently.
Psoriasis
Acebutolol Gedeon Richter can be used in patients with psoriasis after weighing the benefits and risks of such treatment. Exacerbation of psoriasis and psoriatic skin symptoms has been reported after administration of beta-adrenergic blockers.
Hypersensitivity reactions
Acebutolol Gedeon Richter and other beta-adrenergic blockers may exacerbate hypersensitivity reactions.
Special caution is recommended when using the medicine in patients who have previously experienced such reactions, for example, in connection with the use of iodine-containing contrast agents (used in some X-ray examinations) or after administration of flecainide.
General anesthesia
Acebutolol Gedeon Richter increases the risk of hypotension (blood pressure below 100/60 mmHg) in patients undergoing general anesthesia. It is recommended to discontinue the medicine 48 hours before general anesthesia. The anesthesiologist should be informed about the use of Acebutolol Gedeon Richter.
Athletes
Acebutolol Gedeon Richter contains an active substance that can cause positive results in anti-doping tests conducted by some sports federations and relevant authorities.
It is recommended to consult a doctor even if the above warnings refer to situations that occurred in the past.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Medicines that should not be taken with Acebutolol Gedeon Richter or whose use with Acebutolol Gedeon Richter requires special attention:
Medicines that should be used with caution with Acebutolol Gedeon Richter:
The medicine should be taken orally. It is recommended to take the medicine during a meal. The tablet should be swallowed whole and washed down with water.
If the patient is pregnant or breastfeeding, or thinks they may be pregnant or plans to have a child, they should consult a doctor or pharmacist before taking this medicine.
Acebutolol Gedeon Richter should not be taken during pregnancy.
Beta-adrenergic blockers may reduce blood flow to the placenta, which can lead to premature birth, lower than expected birth weight, fetal death in the womb, and miscarriage.
Acebutolol Gedeon Richter passes into breast milk in significant amounts. Breastfeeding women should not take Acebutolol Gedeon Richter.
Acebutolol Gedeon Richter has a minor effect on the ability to drive and use machines.
The medicine may cause dizziness and fatigue in treated patients. If these symptoms occur, do not drive or operate machinery.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult a doctor before taking this medicine.
Each Acebutolol Gedeon Richter 200 mg coated tablet contains no more than 132 micrograms of gluten.
Each Acebutolol Gedeon Richter 400 mg coated tablet contains no more than 118 micrograms of gluten.
This medicine contains very small amounts of gluten (derived from wheat starch). Therefore, it is very unlikely to cause problems in patients with celiac disease.
Patients with a wheat allergy (other than celiac disease) should not take this medicine.
This medicine should always be taken as directed by a doctor or pharmacist. In case of doubts, consult a doctor or pharmacist.
The most commonly used dosage in hypertension is:
The most commonly used dosage in coronary artery disease is:
The most commonly used dosage in heart rhythm disorders is:
Tablets should be taken during a meal, at the same time of day, swallowed whole, and washed down with water.
Taking the medicine at the same time of day helps prevent missed doses.
If you feel that the effect of Acebutolol Gedeon Richter is too strong or too weak, consult a doctor.
In case of taking a higher dose of the medicine than recommended, immediately consult a doctor or go to the hospital. Show the doctor the package with the tablets.
In case of taking a higher dose of Acebutolol Gedeon Richter than recommended, the patient may experience severe bradycardia (below 50 heartbeats/minute) (the heart rate may become very slow or the heart may stop) or hypotension (blood pressure below 100/60 mmHg). Other symptoms of overdose include: shock, atrioventricular block, sinus block, and other conduction disorders, pulmonary edema, disorders of consciousness, bronchospasm, hypoglycemia (blood glucose level below 50 mg/dl), and in rare cases, hyperkalemia (increased potassium levels in the blood).
If a dose is missed and it has not been more than 8 hours since the planned time of taking the medicine, take it on the same day. If more than 8 hours have passed since the planned time of taking the medicine, take the next prescribed dose at the scheduled time.
Do not take a double dose to make up for a missed dose.
Do not stop taking Acebutolol Gedeon Richter abruptly, especially in patients with coronary artery disease. The doses should be gradually reduced over 1-2 weeks, if necessary, changing the treatment to prevent exacerbation of coronary artery disease.
Like all medicines, Acebutolol Gedeon Richter can cause side effects, although not everybody gets them.
The side effects of Acebutolol Gedeon Richter are listed below.
If a side effect is described in the leaflet as:
Severe side effects occur rarely (most commonly observed is severe bradycardia).
Other severe side effects include: bronchospasm, severe pneumonia, heart failure.
Among other side effects, the most common are gastrointestinal disorders and nervous system disorders (headache, dizziness, insomnia).
Frequent side effects include:
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
Store the medicine out of sight and reach of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the packaging after "EXP". The expiry date refers to the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Acebutolol Gedeon Richter, 200 mg, coated tablets
Round, biconvex, coated tablets, 12 mm in diameter, white to cream-colored, with "200" embossed on one side of the tablet and a score line on the other side of the tablet. The score line on the tablet is only to facilitate breaking the tablet to make it easier to swallow, and not to divide it into equal doses.
Acebutolol Gedeon Richter, 400 mg, coated tablets
Round, biconvex, coated tablets, 12 mm in diameter, light cream to cream-colored, with "400" embossed on one side of the tablet and a score line on the other side of the tablet. The score line on the tablet is only to facilitate breaking the tablet to make it easier to swallow, and not to divide it into equal doses.
Acebutolol Gedeon Richter is packaged in blisters of aluminum/PVC foil placed in a cardboard box. The box contains 30 coated tablets and a patient information leaflet.
GEDEON RICHTER POLSKA Sp. z o.o.
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
phone: (22) 755 50 81
To obtain more detailed information about the medicine, contact:
GEDEON RICHTER POLSKA Sp. z o.o.
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
Phone: +48 (22)755 96 48
lekalert@grodzisk.rgnet.org
((logo of the marketing authorization holder))
((pharmacode))
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.